MiCheck®

#MiCheck® Prostate is a novel #Australian technology and a risk score for aggressive prostate cancer. It's a lead product in the pipeline of @MinomicInt

[Minomic Int'l @MinomicInt]

We had the opportunity to share Minomic’s journey from genesis of the company to launch of MiCheck® Prostate in the US market with @360DxNews, a leading media outlet for the #diagnostics industry.

Subscribe to 360Dx to read the full article: https://t.co/0VQAlBPOqq

[Minomic Int'l @MinomicInt]

The number of men being diagnosed with #ProstateCancer is expected to increase by as much as 43% between now and 2040. Early and accurate diagnosis is key to boosting survival rates. MiCheck® Prostate is designed to better-detect aggressive prostate cancer.

[Minomic Int'l @MinomicInt]

#prostatecancer #detection #USANZ22

[Minomic Int'l @MinomicInt]

View the presentation of CEO Brad Walsh @drbrad69 on MiCheck® Prostate in the video https://t.co/uyloegALSK
#ProstateCancer

[Minomic Int'l @MinomicInt]

Minomic is pleased to be part of the Australian Government vision to build sovereign capability. Read more: https://t.co/hMDiPww0R2
#ProstateCancer #Investment #MedTech

[Minomic Int'l @MinomicInt]

According to Dr @LoebStacy, younger men who consume healthy #plantbased foods, dramatically lower their risk of developing advanced #ProstateCancer
https://t.co/MT7H0i6mQo

[Minomic Int'l @MinomicInt]

Minomic is thrilled to cooperate with the #CLIAx team that allows us to tap into the expertise in laboratory testing. It is a ‘soft landing’ site to enter the U.S. market for MiCheck Prostate test rollout. https://t.co/CvNt3jKhRc

[Minomic Int'l @MinomicInt]

These findings highlight the importance of considering mental wellbeing during follow-up for early recognition and treatment of #ProstateCancer
https://t.co/oe3iF2rYh6

[Minomic Int'l @MinomicInt]

Widowers are more likely to be diagnosed with advanced #ProstateCancer
https://t.co/uLD9b6gPDE

[The Bridge Program @program_bridge]

Excellent turnout for our 2nd #bridgeprogram2021 seminar presented by Dr Brad Walsh, Phil Hayes-St Clair & Dr Lisa Selbie who shared insights on #leadership & #entrepreneurship in #healthcare. Thanks to all who joined!
@MinomicInt @drbrad69 @UNSWBABS.

[Minomic Int'l @MinomicInt]

Black American military veterans with #aggressive #ProstateCancer who would benefit from surgery or radiation are less likely to get those treatments than men of other races, despite equal access to health care, a new study finds.
https://t.co/PdvLhmq6m3

[Minomic Int'l @MinomicInt]

Poor patients with low household #income have worse #ProstateCancer at diagnosis. These patients have different goals of care which impact their choice of treatment.
https://t.co/KLtNXx8d0r

[Minomic Int'l @MinomicInt]

Association between #environmental quality and #ProstateCancer stage at diagnosis

[MiCheck® @micheck_test]

Association between environmental quality and prostate cancer stage at diagnosis
https://t.co/e4jCXuqXt9

[Minomic Int'l @MinomicInt]

This increase in the incidence rates appears to be related to an increased life expectancy. Increasing incidence rate trends in developing countries are likely due to improved access to medical care as well as increased documentation and reporting of cases.

[Minomic Int'l @MinomicInt]

We are thrilled to announce that Minomic and GloriousMed executed an agreement formally launching the commercialization pathway for MiCheck® Prostate, in mainland China.
Discover more: https://t.co/IRp7wNuHfY
@drbrad69
@micheck_test
#ProstateCancer

[Minomic Int'l @MinomicInt]

A recent study shows an expansion of #Medicare in the US would improve #ProstateCancer outcomes for the #elderly
https://t.co/c3r7IriPMV

[Minomic Int'l @MinomicInt]

On 24 March 2021 at Senate Alcove, Parliament House Canberra, Dr Brad Walsh, CEO of Minomic International Ltd, opened the innovations panel discussion.
Discover more: https://t.co/zKxkz7BLYp

[Minomic Int'l @MinomicInt]

#ProstateCancer becomes commoner and deadlier in #China
https://t.co/dNOvslasIj

[Minomic Int'l @MinomicInt]

Depression common after #ProstateCancer diagnosis, incidence higher in #BlackMen. #Depression in Black patients was also associated with increased mortality. https://t.co/ItZAbPjIAA